Analysts Issue Forecasts for ACHC FY2024 Earnings

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Investment analysts at KeyCorp issued their FY2024 earnings per share estimates for shares of Acadia Healthcare in a report released on Monday, January 6th. KeyCorp analyst M. Gillmor forecasts that the company will post earnings of $3.39 per share for the year. KeyCorp currently has a “Overweight” rating and a $70.00 price target on the stock. The consensus estimate for Acadia Healthcare’s current full-year earnings is $3.38 per share. KeyCorp also issued estimates for Acadia Healthcare’s Q4 2024 earnings at $0.73 EPS, Q1 2025 earnings at $0.66 EPS, Q4 2025 earnings at $0.77 EPS, FY2025 earnings at $3.20 EPS and FY2026 earnings at $3.98 EPS.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.90 by $0.01. The firm had revenue of $815.60 million during the quarter, compared to analysts’ expectations of $819.42 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The company’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.91 EPS.

Several other equities research analysts have also weighed in on ACHC. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and upped their price objective for the company from $45.00 to $75.00 in a research note on Thursday, December 12th. Cantor Fitzgerald restated a “neutral” rating and set a $52.00 price target on shares of Acadia Healthcare in a research report on Tuesday, December 10th. Barclays decreased their price target on Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating on the stock in a research report on Friday, November 22nd. Royal Bank of Canada reaffirmed an “outperform” rating and set a $64.00 price objective on shares of Acadia Healthcare in a report on Friday. Finally, StockNews.com downgraded Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Monday, January 6th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $70.22.

Acadia Healthcare Trading Down 0.4 %

Acadia Healthcare stock opened at $44.92 on Thursday. The business has a 50 day moving average price of $40.48 and a two-hundred day moving average price of $58.19. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. The stock has a market cap of $4.17 billion, a price-to-earnings ratio of 14.73, a price-to-earnings-growth ratio of 1.77 and a beta of 1.29. Acadia Healthcare has a 12 month low of $36.50 and a 12 month high of $87.77.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. GAMMA Investing LLC raised its stake in Acadia Healthcare by 57.1% during the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock worth $42,000 after buying an additional 241 shares during the period. Point72 Asia Singapore Pte. Ltd. bought a new position in Acadia Healthcare during the second quarter worth about $59,000. Covestor Ltd lifted its holdings in Acadia Healthcare by 834.4% during the third quarter. Covestor Ltd now owns 1,140 shares of the company’s stock worth $72,000 after acquiring an additional 1,018 shares in the last quarter. DekaBank Deutsche Girozentrale bought a new position in Acadia Healthcare during the third quarter worth about $86,000. Finally, Assetmark Inc. lifted its holdings in Acadia Healthcare by 66.1% during the third quarter. Assetmark Inc. now owns 1,485 shares of the company’s stock worth $94,000 after acquiring an additional 591 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.